X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-02-12 | DCOM | Dime Community Bancshares, Inc. /ny/ | Basswood Capital Management, L.L.C. | Director-by-Deputization | P - Purchase | $31.30 | +316 | 2,057,957 | 0% | +$9,891 | ||||||
2025-02-12 | DCOM | Dime Community Bancshares, Inc. /ny/ | Basswood Capital Management, L.L.C. | Director-by-Deputization | S - Sale | $31.20 | -9,815 | 2,057,957 | 0% | -$306,228 | ||||||
| M | 2025-02-12 | CMPO | Composecure, Inc. | Resolute Compo Holdings LLC | Dir, 10% | P - Purchase | $15.44 | +646,893 | 49,937,302 | +1% | +$9,986,150 | |||||
| M | 2025-02-12 | CMPO | Composecure, Inc. | Knott Thomas R. | Dir, 10% | P - Purchase | $15.44 | +646,893 | 49,937,302 | +1% | +$9,986,150 | |||||
| M | 2025-02-12 | CMPO | Composecure, Inc. | Cote John D. | Dir, 10% | P - Purchase | $15.44 | +646,893 | 51,437,302 | +1% | +$9,986,150 | |||||
| DM | 2025-02-12 | SCHW | Schwab Charles Corp | Schwab Charles R. | Co-COB | S - Sale+OE | $81.74 | -305,506 | 98,474,071 | 0% | -$24,971,294 | |||||
| DM | 2025-02-13 | AXSM | Axsome Therapeutics, Inc. | Pizzie Nick | CFO | S - Sale+OE | $130.10 | -15,000 | 42,675 | -26% | -$1,951,530 | |||||
| M | 2025-02-12 | PBI | Pitney Bowes Inc /de/ | Wolf Kurt James | Dir | S - Sale | $9.88 | -1,604,678 | 14,186,244 | -10% | -$15,853,104 | |||||
| DM | 2025-02-12 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | S - Sale+OE | $10.47 | -435,425 | 896,869 | -33% | -$4,561,041 | |||||
2025-02-12 | PSMT | Pricesmart Inc | Fisher Jeffrey | Dir | S - Sale | $95.02 | -200 | 17,653 | -1% | -$19,004 | ||||||
2025-02-14 | TEAM | Atlassian Corp | Bharadwaj Anutthara | Pres | S - Sale | $312.58 | -1,520 | 201,657 | -1% | -$475,122 | ||||||
2025-02-14 | TEAM | Atlassian Corp | Liu Gene | Chief Accounting Officer | S - Sale | $312.09 | -568 | 52,262 | -1% | -$177,264 | ||||||
| D | 2025-02-14 | IE | Ivanhoe Electric Inc. | Friedland Robert M | Exec COB | P - Purchase | $0.00 | +816,667 | 10,773,303 | +8% | +$0 | |||||
2025-02-14 | TEAM | Atlassian Corp | Rajan Rajeev Bashyam | CTO | S - Sale | $312.09 | -3,111 | 183,878 | -2% | -$970,912 | ||||||
2025-02-13 | HLI | Houlihan Lokey, Inc. | Zucker Gillian Beth | Dir | S - Sale | $178.97 | -200 | 5,801 | -3% | -$35,794 | ||||||
| M | 2025-02-12 | SPFI | South Plains Financial, Inc. | Griffith Curtis C | COB, CEO, 10% | S - Sale | $35.54 | -38,557 | 1,721,043 | -2% | -$1,370,429 | |||||
2025-02-14 | TEAM | Atlassian Corp | Bharadwaj Anutthara | Pres | S - Sale | $312.09 | -7,294 | 203,177 | -3% | -$2,276,388 | ||||||
2025-02-14 | CLSK | Cleanspark, Inc. | Monnig Taylor | CTO | S - Sale | $10.64 | -239 | 201,281 | 0% | -$2,543 | ||||||
2025-02-14 | CLSK | Cleanspark, Inc. | Schultz S. Matthew | Exec COB | S - Sale | $10.64 | -9,010 | 3,471,006 | 0% | -$95,861 | ||||||
| D | 2025-02-12 | DKNG | Draftkings Inc. | Robins Jason | See Remarks | S - Sale+OE | $45.00 | -200,000 | 2,678,703 | -7% | -$9,000,000 | |||||
2025-02-14 | CLSK | Cleanspark, Inc. | Garrison Scott Eugene | COO | S - Sale | $10.64 | -1,337 | 196,059 | -1% | -$14,225 | ||||||
2025-02-14 | CLSK | Cleanspark, Inc. | Vecchiarelli Gary Anthony | CFO | S - Sale | $10.64 | -717 | 564,998 | 0% | -$7,628 | ||||||
2025-02-12 | BYRN | Byrna Technologies Inc. | Pham Luan | Chief Mktg, Rev Officer | S - Sale | $30.19 | -33,483 | 19,148 | -64% | -$1,010,905 | ||||||
2025-02-14 | CLSK | Cleanspark, Inc. | Bradford Zachary | CEO, Pres | S - Sale | $10.64 | -10,533 | 3,883,190 | 0% | -$112,065 | ||||||
2025-02-14 | TEAM | Atlassian Corp | Binz Joseph Leo | CFO | S - Sale | $312.09 | -2,587 | 169,342 | -2% | -$807,378 | ||||||
| M | 2025-02-12 | VISL | Vislink Technologies, Inc. | Hale Capital Partners, LP | 10% | P - Purchase | $2.46 | +28,993 | 304,408 | +11% | +$71,342 | |||||
2025-02-14 | TEAM | Atlassian Corp | Cannon-Brookes Michael | CEO, Co-Founder, 10% | S - Sale | $311.90 | -7,948 | 238,440 | -3% | -$2,479,015 | ||||||
2025-02-14 | TEAM | Atlassian Corp | Farquhar Scott | Dir, 10% | S - Sale | $311.90 | -7,948 | 238,440 | -3% | -$2,479,014 | ||||||
2025-02-14 | TEM | Tempus Ai, Inc. | Doudna Jennifer A | Dir | S - Sale | $90.00 | -1,320 | 36,011 | -4% | -$118,800 | ||||||
| M | 2025-02-12 | KALV | Kalvista Pharmaceuticals, Inc. | Venrock Healthcare Capital Partners Iii, L.P. | 10% | P - Purchase | $9.27 | +161,700 | 5,278,985 | +3% | +$1,498,661 | |||||
| DM | 2025-02-12 | RVLV | Revolve Group, Inc. | Mente Michael | CO-CEO, 10% | S - Sale+OE | $30.89 | -201,761 | 73,000 | -73% | -$6,231,746 | |||||
| DM | 2025-02-12 | RVLV | Revolve Group, Inc. | Karanikolas Michael | CO-CEO, 10% | S - Sale+OE | $30.89 | -201,761 | 123,000 | -62% | -$6,231,746 | |||||
| DM | 2025-02-12 | RVLV | Revolve Group, Inc. | Mmmk Development, Inc. | 10% | S - Sale+OE | $30.89 | -201,761 | 0 | -100% | -$6,231,746 | |||||
| M | 2025-02-12 | MDBH | Mdb Capital Holdings, LLC | Digiandomenico Anthony | Co-Founder, 10% | P - Purchase | $6.15 | +1,232 | 94,274 | +1% | +$7,577 | |||||
2025-02-12 | EGBN | Eagle Bancorp Inc | Saltzman Paul | EVP, GC | S - Sale | $25.53 | -3,000 | 18,177 | -14% | -$76,590 | ||||||
| D | 2025-02-13 | NBIX | Neurocrine Biosciences Inc | Cooke Julie | CHRO | S - Sale+OE | $116.78 | -1,551 | 20,190 | -7% | -$181,129 | |||||
2025-02-12 | AMP | Ameriprise Financial Inc | Sharpe Robert Francis Jr | Dir | S - Sale | $523.13 | -1,000 | 15,575 | -6% | -$523,125 | ||||||
| M | 2025-02-11 | SKYH | Sky Harbour Group Corp | Boston Omaha Corp | 10% | S - Sale | $11.20 | -17,227 | 12,215,774 | 0% | -$192,962 | |||||
| M | 2025-02-12 | STAA | Staar Surgical Co | Broadwood Partners, L.P. | 10% | P - Purchase | $15.25 | +411,430 | 22,604,774 | +2% | +$6,274,767 | |||||
| D | 2025-02-13 | NBIX | Neurocrine Biosciences Inc | Gorman Kevin Charles | Dir | S - Sale+OE | $116.69 | -5,844 | 524,209 | -1% | -$681,914 | |||||
2025-02-13 | NBIX | Neurocrine Biosciences Inc | Sherwin Stephen A | Dir | S - Sale | $116.69 | -13,831 | 10,673 | -56% | -$1,613,923 | ||||||
2025-02-13 | QLYS | Qualys, Inc. | Kim Joo Mi | CFO | S - Sale | $140.08 | -4,542 | 108,215 | -4% | -$636,240 | ||||||
2025-02-13 | EMBC | Embecta Corp. | Morris Milton Mayo | Dir | S - Sale | $16.38 | -3,100 | 36,133 | -8% | -$50,783 | ||||||
| DM | 2025-02-13 | NBIX | Neurocrine Biosciences Inc | Roberts Eiry | Chief Medical Officer | S - Sale+OE | $116.44 | -2,218 | 35,640 | -6% | -$258,264 | |||||
2025-02-13 | VIR | Vir Biotechnology, Inc. | Sabatini Brent | SVP, Chief Accounting Officer | S - Sale | $9.15 | -1,562 | 28,189 | -5% | -$14,291 | ||||||
2025-02-12 | PFX | Phenixfin Corp | Hirtler-Garvey Karin | Dir | P - Purchase | $49.27 | +500 | 1,500 | +50% | +$24,635 | ||||||
| D | 2025-02-13 | NBIX | Neurocrine Biosciences Inc | Onyia Jude | Chief Scientific Officer | S - Sale+OE | $116.79 | -2,879 | 18,089 | -14% | -$336,239 | |||||
2025-02-13 | TEAM | Atlassian Corp | Farquhar Scott | Dir, 10% | S - Sale | $316.63 | -7,948 | 246,388 | -3% | -$2,516,541 | ||||||
2025-02-13 | TEAM | Atlassian Corp | Cannon-Brookes Michael | CEO, Co-Founder, 10% | S - Sale | $316.63 | -7,948 | 246,388 | -3% | -$2,516,542 | ||||||
| D | 2025-02-13 | NBIX | Neurocrine Biosciences Inc | Lippoldt Darin | GC | S - Sale+OE | $116.76 | -2,184 | 43,405 | -5% | -$254,992 | |||||
2025-02-13 | ZANDZ | Zillow Group, Inc. | Samuelson Errol G | Chief Industry Dev. Officer | S - Sale | $77.72 | -6,967 | 127,467 | -5% | -$541,471 | ||||||
2025-02-13 | ZANDZ | Zillow Group, Inc. | Choo Jun | COO | S - Sale | $77.72 | -1,277 | 86,853 | -1% | -$99,249 | ||||||
2025-02-13 | ZANDZ | Zillow Group, Inc. | Beitel David A. | CTO | S - Sale | $77.75 | -2,025 | 151,046 | -1% | -$157,452 | ||||||
| D | 2025-02-13 | NBIX | Neurocrine Biosciences Inc | Gano Kyle | CEO | S - Sale+OE | $116.85 | -2,558 | 139,907 | -2% | -$298,908 | |||||
| M | 2025-02-12 | ZANDZ | Zillow Group, Inc. | Rock Jennifer | Chief Accounting Officer | S - Sale | $76.07 | -7,849 | 49,317 | -14% | -$597,077 | |||||
| D | 2025-02-12 | SCHW | Schwab Charles Corp | Bettinger Walter W | Co-COB | S - Sale+OE | $81.91 | -464,629 | 840,580 | -36% | -$38,057,592 | |||||
2025-02-12 | AMTM | Amentum Holdings, Inc. | Demetriou Steven J. | Exec Chair | P - Purchase | $20.81 | +100,000 | 644,443 | +18% | +$2,080,700 | ||||||
| D | 2025-02-13 | NBIX | Neurocrine Biosciences Inc | Delaet Ingrid | Chief Regulatory Officer | S - Sale+OE | $116.71 | -1,471 | 4,730 | -24% | -$171,674 | |||||
| D | 2025-02-14 | FENC | Fennec Pharmaceuticals Inc. | Rallis Chris A | Dir | S - Sale+OE | $6.82 | -1,186 | 53,020 | -2% | -$8,089 | |||||
2025-02-14 | ARW | Arrow Electronics, Inc. | Cho Yun Sung | VP, Corp. Cont., CAO | S - Sale | $108.73 | -237 | 2,086 | -10% | -$25,769 | ||||||
| D | 2025-02-13 | NBIX | Neurocrine Biosciences Inc | Boyer David W. | Chief Corp. Affairs Officer | S - Sale+OE | $116.74 | -1,785 | 3,565 | -33% | -$208,387 | |||||
| D | 2025-02-13 | NBIX | Neurocrine Biosciences Inc | Benevich Eric | Chief Commercial Officer | S - Sale+OE | $116.73 | -2,154 | 44,689 | -5% | -$251,428 | |||||
| DM | 2025-02-13 | JCI | Johnson Controls International Plc | Oliver George | COB, CEO | S - Sale+OE | $88.86 | -325,788 | 1,382,242 | -19% | -$28,950,428 | |||||
2025-02-12 | OVLY | Oak Valley Bancorp | Barton Don | Dir | S - Sale | $27.39 | -375 | 35,625 | -1% | -$10,272 | ||||||
2025-02-13 | RCL | Royal Caribbean Cruises Ltd | Fain Richard D | Dir | S - Sale | $256.68 | -19,500 | 471,474 | -4% | -$5,005,338 | ||||||
| D | 2025-02-13 | NBIX | Neurocrine Biosciences Inc | Abernethy Matt | CFO | S - Sale+OE | $116.86 | -2,558 | 35,810 | -7% | -$298,923 | |||||
2025-02-13 | ZVRA | Zevra Therapeutics, Inc. | Sangiovanni Timothy J. | SVP, Finance, Corp Controller | S - Sale | $7.86 | -3,000 | 16,341 | -16% | -$23,588 | ||||||
2025-02-13 | ZVRA | Zevra Therapeutics, Inc. | Schafer Joshua | CCO, EVP, Bus. Development | S - Sale | $7.86 | -10,500 | 29,486 | -26% | -$82,527 | ||||||
2025-02-13 | ZVRA | Zevra Therapeutics, Inc. | Clifton R. Laduane | CFO, Treasurer | S - Sale | $7.86 | -11,000 | 51,361 | -18% | -$86,471 | ||||||
| M | 2025-02-13 | ZVRA | Zevra Therapeutics, Inc. | McFarlane Neil F. | Pres, CEO | S - Sale | $7.92 | -91,817 | 191,516 | -32% | -$727,390 | |||||
2025-02-14 | PNR | Pentair Plc | Pilla Stephen J | EVP Ch Sup Chn Of Ch Trnfrm O | S - Sale | $98.14 | -7,200 | 26,002 | -22% | -$706,608 | ||||||
2025-02-11 | LWAY | Lifeway Foods, Inc. | Smolyansky Ludmila | Member of 10% owner group | S - Sale | $21.31 | -10,000 | 1,058,166 | -1% | -$213,100 | ||||||
| M | 2025-02-13 | IBEX | Ibex Ltd | Khaishgi Mohammedulla | Dir | S - Sale | $26.89 | -45,200 | 148,005 | -23% | -$1,215,508 | |||||
2025-02-13 | CMRX | Chimerix Inc | Melemed Allen S. | Chief Medical Officer | S - Sale | $4.50 | -3,065 | 152,875 | -2% | -$13,799 | ||||||
2025-02-13 | CMRX | Chimerix Inc | Andriole Michael T. | Pres, CEO | S - Sale | $4.52 | -7,370 | 609,603 | -1% | -$33,282 | ||||||
2025-02-13 | SCCO | Southern Copper Corp/ | Palomino Bonilla Luis Miguel | Dir | S - Sale | $94.00 | -100 | 2,813 | -3% | -$9,400 | ||||||
2025-02-13 | CMRX | Chimerix Inc | Alrutz Michael Albert | SVP, GC | S - Sale | $4.52 | -1,600 | 213,596 | -1% | -$7,226 | ||||||
2025-02-12 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $26.54 | -92 | 262,623 | 0% | -$2,442 | ||||||
2025-02-13 | CMRX | Chimerix Inc | Jakeman David | VP of Finance, Accounting | S - Sale | $4.53 | -300 | 148,987 | 0% | -$1,360 | ||||||
2025-02-12 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $26.54 | -159 | 121,620 | 0% | -$4,220 | ||||||
2025-02-12 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $26.54 | -78 | 156,567 | 0% | -$2,070 | ||||||
2025-02-14 | IBEX | Ibex Ltd | Dechant Robert Thomas | CEO | S - Sale | $27.56 | -5,000 | 213,633 | -2% | -$137,776 | ||||||
2025-02-12 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $26.54 | -102 | 106,962 | 0% | -$2,707 | ||||||
2025-02-12 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $26.54 | -53 | 60,191 | 0% | -$1,407 | ||||||
2025-02-13 | CMRX | Chimerix Inc | Laspaluto Michelle | CFO | S - Sale | $4.51 | -2,260 | 172,977 | -1% | -$10,196 | ||||||
2025-02-14 | IBEX | Ibex Ltd | Inson Paul Joseph | Chief People Officer | S - Sale | $27.53 | -8,954 | 21,042 | -30% | -$246,520 | ||||||
| D | 2025-02-12 | VIRT | Virtu Financial, Inc. | Fairclough Brett | Co-Pres, Co-COO | S - Sale+OE | $36.84 | -72,967 | 90,749 | -45% | -$2,688,440 | |||||
| D | 2025-02-13 | JOBY | Joby Aviation, Inc. | Dehoff Kate | See Remarks | S - Sale+OE | $7.43 | -6,903 | 202,276 | -3% | -$51,289 | |||||
| D | 2025-02-13 | JOBY | Joby Aviation, Inc. | Bevirt Joeben | CEO, Chief Architect, 10% | S - Sale+OE | $7.43 | -10,785 | 94,375,755 | 0% | -$80,133 | |||||
| D | 2025-02-13 | JOBY | Joby Aviation, Inc. | Allison Eric | Chief Product Officer | S - Sale+OE | $7.43 | -6,903 | 586,314 | -1% | -$51,289 | |||||
| D | 2025-02-13 | JOBY | Joby Aviation, Inc. | Simi Bonny W | Pres of Operations | S - Sale+OE | $7.43 | -8,628 | 154,438 | -5% | -$64,106 | |||||
| DM | 2025-02-13 | JOBY | Joby Aviation, Inc. | Bowles Gregory | See Remarks | S - Sale+OE | $7.64 | -16,020 | 29,235 | -35% | -$122,418 | |||||
| DM | 2025-02-13 | JOBY | Joby Aviation, Inc. | Papadopoulos Didier | Pres of Aircraft OEM | S - Sale+OE | $7.57 | -21,285 | 60,121 | -26% | -$161,208 | |||||
| DM | 2023-05-22 | BLTH | American Battery Materials, Inc. | Glenn Dylan | Dir | P - Purchase | $0.15 | +2,224 | 8,029 | +38% | +$342 | |||||
| D | 2025-02-13 | CWAN | Clearwater Analytics Holdings, Inc. | Sahai Sandeep | CEO | S - Sale+OE | $27.63 | -50,000 | 615,855 | -8% | -$1,381,560 | |||||
| M | 2025-02-13 | HBT | Hbt Financial, Inc. | Drake Fred L | Exec COB, 10% | S - Sale | $25.17 | -12,825 | 17,276,403 | 0% | -$322,747 | |||||
2025-02-13 | PFE | Pfizer Inc | Blaylock Ronald E | Dir | P - Purchase | $25.65 | +19,457 | 32,457 | +150% | +$499,072 | ||||||
| DM | 2025-02-12 | ALKS | Alkermes Plc. | Hopkinson Craig C. | EVP R, D, Chief Medical Office | S - Sale+OE | $33.92 | -349,340 | 57,875 | -86% | -$11,848,975 | |||||
| DM | 2025-02-13 | GL | Globe Life Inc. | Svoboda Frank M | Co-COB, CEO | S - Sale+OE | $122.42 | -21,750 | 165,781 | -12% | -$2,662,709 | |||||
2025-02-14 | K | Kellanova | Kellogg W K Foundation Trust | 10% | S - Sale | $82.25 | -114,583 | 48,076,612 | 0% | -$9,424,773 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |